Schizophrenia: open trials in China

57 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07918222
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
Trial Treatment · Phase 3 · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai
Registry updated 2026-11-05
NCT07911787
Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults
Trial Treatment · Phase 3 · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Shanghai Mental Health Center, Shanghai
Registry updated 2026-11-03
NCT07815210
Phase I Trial of HHK101 in Patients With Schizophrenia
Trial Treatment · Phase 1 · Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
Hunan Brain Hospital (The Second People's Hospital of Hunan Province), Changsha · Huzhou No.3 People's Hospital, Huzhou · Shanghai Mental Health Center, Shanghai · Xi'an Mental Health Center, Xi’an
Registry updated 2026-11-02
NCT07701343
tACS for Working Memory in Schizophrenia
Trial Treatment · Central South University
The Second Xiangya Hospital of Central South University, Changsha
Registry updated 2026-10-28
NCT07805980
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
Trial Treatment · Second Xiangya Hospital of Central South University
The Second Xiangya Hospital of Central South University, Changsha
Registry updated 2026-10-28
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Beijing Hospital, Beijing · China-Japan Friendship Hospital, Beijing · Beijing Anding Hospital, Capital Medical University, Beijing · Xiangya Hospital Central South University, Changsha · West China Hospital，Sichuan University, Chengdu · The First Affiliated Hospital of Chongqing Medical University, Chongqing · Guangdong Provincial People's Hospital, Guangzhou · Guangzhou · Zhejiang Hospital - Lingyin Campus, Hangzhou · Zhejiang Provincial People's Hospital, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine - Qiantang Campus, Hangzhou · First Affiliated Hospital of Kunming Medical University, Kunming · The Second Affiliated Hospital of Nanjing Medical University - Main Campus, Nanjing · Nanjing Brain Hospital, Nanjing · The Affiliated Kangning Hospital of Ningbo University - Zhuangshi Campus, Ningbo · Shanghai Mental Health Center - PPDS, Shanghai · Tongji Hospital of Tongji University, Shanghai · Shanghai · Shenzhen Kangning Hospital, Shenzhen · Tianjin Anding Hospital(Tianjin mental Health Center), Tianjin · The Mental Health Center of Xi'an, Xi'an · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-10-27
NCT07795554
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Trial Treatment · Second Xiangya Hospital of Central South University
The Second Xiangya Hospital of Central South University, Changsha
Registry updated 2026-10-27
NCT07887997
Temporal Interference Stimulation (TI) for Schizophrenia (SCZ)
Trial Treatment · Anhui Medical University
The First Affiliated Hospital of Anhui Medical University, Hefei
Registry updated 2026-10-22
NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Trial Treatment · Phase 2 · Eli Lilly and Company
The Second Xiangya Hospital of Central South University, Changsha · The Fourth People's Hospital of Chengdu, Chengdu · The Seventh People's Hospital of Hangzhou, Hangzhou · Suzhou Guangji Hospital, Suzhou · Tianjin Anding Hospital, Tianjin · Wuhu Hospital of Beijing Anding hospital, Wuhu · Xi'an Mental Health Center, Xi’an · Zhumadian Psychiatric Hospital, Zhumadian
Registry updated 2026-10-07
NCT07356765
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
Trial Treatment · Tianjin Anding Hospital
Tianjin Anding Hospital, Tianjin
Registry updated 2026-09-21
NCT07818668
tACS for Self-Other Boundary in Schizophrenia
Trial Treatment · Chunyan Zhu
The Fourth People's Hospital of Hefei, Hefei
Registry updated 2026-09-17
NCT07559084
Multi-target TMS for Schizophrenia Negative Symptoms
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-09-10
NCT07781748
Improving Quality of Informal Care for People With Schizophrenia
Trial Treatment · Chinese University of Hong Kong
Xinjin Second Peope's Hospital, Chengdu
Registry updated 2026-08-25
NCT07658898
dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia
Trial Treatment · Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Shanghai Pudong New Area Mental Health Center, Shanghai
Registry updated 2026-08-21
NCT06112067
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
Trial Treatment · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-08-20
NCT07767526
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Trial Treatment · Phase 1/2 · Shanghai Mental Health Center
Shanghai Mental Health Center, Shanghai
Registry updated 2026-08-17
NCT06504290
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Trial Treatment · Phase 1 · Vigonvita Life Sciences
Beijing Huilongguan Hospital, Beijing · Beijing Anding Hospital of Capital Medical University, Beijing · Xi'an Mental Health Center, Xi’an
Registry updated 2026-08-14
NCT07759869
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Trial Treatment · Phase 3 · Jiangsu Hansoh Pharmaceutical Co., Ltd.
Peking University Sixth Hospital, Beijing
Registry updated 2026-08-12
NCT07045142
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
Trial Treatment · Phase 3 · Central South University
The Third Hospital of Changsha County, Changsha · Mental Health Institute of Second Xiangya Hospital,CSU, Changsha · The Second People's Hospital of Dali Bai Autonomous Prefecture, Dali · Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals District, Xiangshan · The Second People's Hospital of Xiangyin County, Yueyang · Yueyang Rehabilitation Hospital, Yueyang · Junshan District Psychiatric Rehabilitation Hospital, Yueyang · Zhumadian Second People's Hospital, Zhumadian
Registry updated 2026-08-03
NCT06673966
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
Research · Central South University
Department of Psychiatry, the Second Xiangya Hospital of Central South University, Changsha
Registry updated 2026-07-17
NCT07647380
TIS for Improving Cognitive Impairment in Schizophrenia
Trial Treatment · Central South University
Second Xiangya Hospital, Central South University, Changsha
Registry updated 2026-07-17
NCT07703956
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
Trial Treatment · Phase 2 · Vigonvita Life Sciences
Beijing Anding Hospital of Capital Medical University, Beijing
Registry updated 2026-07-15
NCT06674694
The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Trial Treatment · Phase 1 · Sichuan Kelun Pharmaceutical Co.,Ltd.
Beijing Anding Hospital, Capital Medical University, Beijing
Registry updated 2026-06-29
NCT07616999
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
Research · The University of Hong Kong
Department of Psychiatry, Queen Mary Hospital, Hong Kong
Registry updated 2026-06-26
NCT07671261
SEEG-Guided DBS for Schizophrenia
Trial Treatment · Ruijin Hospital
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai
Registry updated 2026-06-26

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error